ストックスクリーナーアプリを入手
2.82
3.75%
-0.11
アフターアワーズ：
2.89
0.07
+2.48%
前日終値:
$2.93
開ける：
$2.93
24時間の取引高:
17,730
Relative Volume:
0.08
時価総額：
$2.78M
収益：
$7.68M
当期純損益:
$-34.33M
株価収益率:
-0.032
EPS:
-88.1566
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
-1.05%
1か月 パフォーマンス:
-22.10%
6か月 パフォーマンス:
-80.13%
1年 パフォーマンス:
-94.36%
1日の値動き範囲:
$2.82
$2.99
1週間の範囲:
$2.38
$2.99
52週間の値動き範囲:
$2.38
$55.60
Beyond Air Inc Stock (XAIR) Company Profile
Compare XAIR vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
2.82 | 2.81M | 7.68M | -34.33M | -19.17M | -88.16 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | D. Boral Capital | Buy |
| 2024-06-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-07-28 | 開始されました | Piper Sandler | Overweight |
| 2023-06-15 | 開始されました | BTIG Research | Buy |
| 2021-04-28 | 開始されました | Truist | Buy |
| 2019-10-22 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Beyond Air Inc (XAIR) 最新ニュース
Beyond Air Slips After Disclosure of Long-Term Employment Contract for CEO - Moomoo
Beyond Air Formalizes CEO Agreement, Boosts CFO Compensation - TipRanks
Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag? - Stocktwits
Beyond Air, Inc. Revenue Breakdown – GETTEX:48L - TradingView
Beyond Air, Long Island company, covered up defects in device treating cancer patients, lawsuit says - Newsday
XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada
XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView
Beyond Air at cantors conference: generation 2 is the focus - Investing.com India
Beyond Air Inc (NASDAQ: XAIR) Share Price, XAIR Stock News, XAIR Share Price & Updates - Kalkine
At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference - Yahoo Finance
XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus
Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com
Lake Street Initiates Beyond Air(XAIR.US) With Buy Rating, Announces Target Price $10 - Moomoo
XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times
Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative
A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan
Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity - Investing.com India
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air Inc (XAIR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
Beyond Air Inc (XAIR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XAIR Q2 2026 Earnings: Narrower Loss Fails to Stem 8.74% Stock DeclineEarnings Sentiment Score - vinanet.vn
Beyond Air Sticks to Revenue Targets as LungFit PH Gen II FDA Decision Nears - finance.biggo.com
Beyond Air Inc (XAIR) Stock News Today - TradingKey
Beyond Air (XAIR) Surges 14.4% to $6.92 as Bulls Defend SupportRisk Parity Rebalance - vinanet.vn
Beyond Air (XAIR) gains 5.30% beneficial owner as Balyasny Asset Management reports 763,266 shares - Stock Titan
XAIR|Beyond Air Inc|Price:7.160|Chg%:+1.110 - TradingKey
Beyond Air (XAIR) Earnings Call zum 1. Quartal des Geschäftsjahres 2027: FDA-Katalysator, Ausblick von 8 Mio. USD für 2026 - TradingKey
Beyond Air (XAIR) Fiscal Q1 2027 Earnings Call: FDA Catalyst, $8M 2026 Outlook - TradingKey
Beyond Air earnings missed by $0.10, revenue fell short of estimates - Investing.com Canada
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript - AOL.com
XAIR | Beyond Air, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strate - GuruFocus
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ... - Yahoo Finance UK
Beyond Air, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Beyond Air (XAIR) posts $7.9M loss and cites funding risk in quarter - Stock Titan
Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Beyond Air Releases Q1 2027 Financial Results - AlphaStreet
XAIR: Gross margin rose to 13% as pipeline doubled and 2026 revenue guidance was reaffirmed at $8M - TradingView
Beyond Air Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Beyond Air misses Q1 2027 revenue view, shares fall premarket - Investing.com
Beyond Air Inc (XAIR) 財務データ
収益
当期純利益
現金流量
EPS
Beyond Air Inc (XAIR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MOORHEAD DANIEL J | Chief Financial Officer |
Jul 29 '26 |
Buy |
5.76 |
4,340 |
24,998 |
4,340 |
0.26%
0.38%
大文字化:
|
ボリューム (24 時間):